REQUEST A DEMO
Total
USD $0.00
Search more companies

Boditech Med Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing | Securities, Commodity Contracts, and Other Financial Investments and Related Activities
Full name: Boditech Med Inc. Profile Updated: February 01, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

NH Special Purpose Acquisition 2nd Co., Ltd. is engaged in acquiring and merging other companies of growth-oriented industries. The company is based in Seoul, South Korea.

Headquarters
43, Geodudanji 1-gil Dongnae-myeon Chuncheon-si Gangwon
Chuncheon; Gangwon; Postal Code: 150-747

Contact Details: Purchase the Boditech Med Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Boditech Med Inc. report to view the information.
Outstanding Shares:
Purchase the Boditech Med Inc. report to view the information.
Registered Capital:
Purchase the Boditech Med Inc. report to view the information.
Incorporation Date:
September 30, 2014
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
21.1%
Purchase this report to view the information.
8.1%
Purchase this report to view the information.
4%
Company Performance
Financial values in the chart are available after Boditech Med Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-21.35%
Total operating revenue
-21.35%
Operating profit (EBIT)
-58.77%
EBITDA
-54.34%
Net Profit (Loss) for the Period
-40.45%
Total assets
8.36%
Total equity
15.51%
Operating Profit Margin (ROS)
-19.4%
Net Profit Margin
-7.74%
Return on Equity (ROE)
-7.8%
Debt to Equity Ratio
0.22%
Quick Ratio
0.96%
Cash Ratio
-0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?